Frontlight ResearchEarly access
CompletedNo phase
LED Low-Intensity Red Light for Myopia Control in Youth: Efficacy and Safety Study
Key facts
- Who runs it
- Shanghai Eye Disease Prevention and Treatment Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 40 people enrolled
- Started
- 16 Apr 2025
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Red light treatment with 1.6mW LED light source
- Red light treatment with 0.001mW LED light source
- Record updated
- 29 January 2026
Who can take part
- Age
- 8 years to 12 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (13)Hide the full registry criteria
Who can take part
- Age: 8-12 years old
- Simple myopia: equivalent spherical lens ≤ -0.5D and > -6.0D after any cycloplegia, astigmatism ≤ 2.5D, anisometropia ≤ 1.5D
- The best corrected visual acuity in one eye is 0.8 and above
- Normal fundus, or only leopard-shaped fundus
- Sign informed consent and be able to participate in the study
Who cannot take part
- refractive media opacity: corneal opacity, cataract or intraocular lens surgery
- The subject has other congenital eye diseases, such as congenital cataract, congenital glaucoma, etc
- There are eye diseases that affect retinal function
- There are other systemic disease abnormalities
- Rule out hereditary myopia
- Presence of strabismus or other binocular vision abnormalities
- Children who had used or were using orthokeratology, atropine and other myopia control measures could be enrolled after stopping treatment for three months
- Other reasons that the research doctor considers unsuitable for inclusion in the project
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this clinical trial was to investigate the efficacy and safety of repetitive low-intensity single-wavelength red light from an LED light source in controlling myopia progression in children and adolescents.
The 2 groups in the trial
- LED Red light: 1.6 mW/twice dailyTreatment being tested
Treatment: Red light treatment with 1.6mW LED light source
- LED Red light: 0.001 mW/twice dailySham treatment, for comparison
Treatment: Red light treatment with 0.001mW LED light source
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Exploratory Study on the Efficacy and Safety of LED Low-Intensity Red Light for Controlling Myopia Progression in Children and Adolescents
- Publications
- Effect of Photobiomodulation‑Based LED on Myopia Control in Children: An Exploratory Randomized Clinical Trial.Ophthalmology and therapy, 2026
- Record updated
- 29 January 2026